NANOG | Nanog homeobox | Transcription factors
| | | | | Tissue enhanced |
SLC2A3 | Solute carrier family 2 (facilitated glucose transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
FOXJ2 | Forkhead box J2 | Transcription factors
| | | | | Expressed in all |
CLEC4A | C-type lectin domain family 4, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4D | C-type lectin domain family 4, member D | Predicted membrane proteins
| | | | | Group enriched |
MFAP5 | Microfibrillar associated protein 5 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
A2ML1 | Alpha-2-macroglobulin-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
PHC1 | Polyhomeotic homolog 1 (Drosophila) | Disease related genes
| | | | | Expressed in all |
A2M | Alpha-2-macroglobulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
PZP | Pregnancy-zone protein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
CD69 | CD69 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC2B | C-type lectin domain family 2, member B | Predicted secreted proteins
| | | | | Mixed |
CLEC12A | C-type lectin domain family 12, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
OLR1 | Oxidized low density lipoprotein (lectin-like) receptor 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
KLRK1 | Killer cell lectin-like receptor subfamily K, member 1 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
KLRC3 | Killer cell lectin-like receptor subfamily C, member 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
NKG2-E | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
YBX3 | Y box binding protein 3 | Transcription factors
| | | | | Expressed in all |
PRR4 | Proline rich 4 (lacrimal) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ETV6 | Ets variant 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
BCL2L14 | BCL2-like 14 (apoptosis facilitator) | | | | | | Tissue enhanced |
MANSC1 | MANSC domain containing 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DUSP16 | Dual specificity phosphatase 16 | Enzymes
| | | | | Expressed in all |
CDKN1B | Cyclin-dependent kinase inhibitor 1B (p27, Kip1) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
DDX47 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 | Enzymes Plasma proteins
| | | | | Expressed in all |
GPRC5A | G protein-coupled receptor, family C, group 5, member A | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
KIAA1467 | KIAA1467 | Predicted membrane proteins
| | | | | Tissue enhanced |
ATF7IP | Activating transcription factor 7 interacting protein | | | | | | Expressed in all |
HIST4H4 | Histone cluster 4, H4 | Cancer-related genes Disease related genes
| | | | | Mixed |
WBP11 | WW domain binding protein 11 | Predicted membrane proteins
| | | | | Expressed in all |
C12orf60 | Chromosome 12 open reading frame 60 | | | | | | Tissue enhanced |
ERP27 | Endoplasmic reticulum protein 27 | Predicted secreted proteins
| | | | | Tissue enriched |
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
PTPRO | Protein tyrosine phosphatase, receptor type, O | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPS8 | Epidermal growth factor receptor pathway substrate 8 | Disease related genes Plasma proteins
| | | | | Mixed |
STRAP | Serine/threonine kinase receptor associated protein | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
PDE3A | Phosphodiesterase 3A, cGMP-inhibited | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SLCO1B3 | Solute carrier organic anion transporter family, member 1B3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
IAPP | Islet amyloid polypeptide | Predicted secreted proteins
| | | | | Tissue enriched |
RECQL | RecQ protein-like (DNA helicase Q1-like) | Enzymes Plasma proteins
| | | | | Expressed in all |
GOLT1B | Golgi transport 1B | Predicted membrane proteins
| | | | | Expressed in all |
LDHB | Lactate dehydrogenase B | Enzymes Plasma proteins
| | | | | Expressed in all |
CMAS | Cytidine monophosphate N-acetylneuraminic acid synthetase | Enzymes Plasma proteins
| | | | | Expressed in all |
ST8SIA1 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Mixed |
C2CD5 | C2 calcium-dependent domain containing 5 | | | | | | Expressed in all |
ETNK1 | Ethanolamine kinase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
LRMP | Lymphoid-restricted membrane protein | Predicted membrane proteins
| | | | | Tissue enhanced |
ASUN | Asunder spermatogenesis regulator | | | | | | Expressed in all |
FGFR1OP2 | FGFR1 oncogene partner 2 | Disease related genes
| | | | | Expressed in all |
ARNTL2 | Aryl hydrocarbon receptor nuclear translocator-like 2 | Transcription factors
| | | | | Tissue enhanced |